BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 15306592)

  • 1. Morphological characterisation of Crohn's disease fistulae.
    Bataille F; Klebl F; Rümmele P; Schroeder J; Farkas S; Wild PJ; Fürst A; Hofstädter F; Schölmerich J; Herfarth H; Rogler G
    Gut; 2004 Sep; 53(9):1314-21. PubMed ID: 15306592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease.
    Parsi MA; Lashner BA; Achkar JP; Connor JT; Brzezinski A
    Am J Gastroenterol; 2004 Mar; 99(3):445-9. PubMed ID: 15056083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163.
    Demetter P; De Vos M; Van Huysse JA; Baeten D; Ferdinande L; Peeters H; Mielants H; Veys EM; De Keyser F; Cuvelier CA
    Ann Rheum Dis; 2005 Feb; 64(2):321-4. PubMed ID: 15166002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of mast cells and macrophages in focal active gastritis of patients with Crohn's disease.
    Furusu H; Murase K; Nishida Y; Isomoto H; Takeshima F; Mizuta Y; Hewlett BR; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):639-43. PubMed ID: 12063959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronidazole therapy for Crohn's disease and associated fistulae.
    Jakobovits J; Schuster MM
    Am J Gastroenterol; 1984 Jul; 79(7):533-40. PubMed ID: 6741906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microaggregate of immunostained macrophages in noninflamed gastroduodenal mucosa: a new useful histological marker for differentiating Crohn's colitis from ulcerative colitis.
    Yao K; Yao T; Iwashita A; Matsui T; Kamachi S
    Am J Gastroenterol; 2000 Aug; 95(8):1967-73. PubMed ID: 10950044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of 4C8 antigen, a novel transendothelial migration-associated molecule on activated T lymphocytes, in inflammatory bowel disease.
    Oshitani N; Hato F; Kitagawa S; Masuyama J; Higuchi K; Matsumoto T; Arakawa T
    J Pathol; 2002 Aug; 197(5):589-94. PubMed ID: 12210077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease.
    Bataille F; Rohrmeier C; Bates R; Weber A; Rieder F; Brenmoehl J; Strauch U; Farkas S; Fürst A; Hofstädter F; Schölmerich J; Herfarth H; Rogler G
    Inflamm Bowel Dis; 2008 Nov; 14(11):1514-27. PubMed ID: 18626977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intestinal fistulas in Crohn disease].
    Fronda GR; Resegotti A; Astegiano M; Farina EC; Patelli E; Giustetto A; De Paolis P
    Minerva Chir; 2000 Jun; 55(6):431-5. PubMed ID: 11059237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of enterovesical fistulas in patients with Crohn's disease.
    Gruner JS; Sehon JK; Johnson LW
    Am Surg; 2002 Aug; 68(8):714-9. PubMed ID: 12206607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical study of colonic mucosa macrophages in children with Crohn's disease and ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(4):283-91. PubMed ID: 10347713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is perianal Crohn's disease associated with intestinal fistulization?
    Sachar DB; Bodian CA; Goldstein ES; Present DH; Bayless TM; Picco M; van Hogezand RA; Annese V; Schneider J; Korelitz BI; Cosnes J;
    Am J Gastroenterol; 2005 Jul; 100(7):1547-9. PubMed ID: 15984979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathological studies of the small intestinal intramural nervous system and of intramural vessels in Crohn's disease.
    Geboes K
    Verh K Acad Geneeskd Belg; 1993; 55(4):267-301; discussion 301-3. PubMed ID: 8128776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspects of Crohn's disease. Report of experience at the Munich surgical university hospital 1954-1974].
    Ruëff F; Grabiger A; Bohmert H; Hamperl D; Hoffman K
    MMW Munch Med Wochenschr; 1975 Jun; 117(23):1009-16. PubMed ID: 807828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activation of the major omentum-associated lymphoid tissue in Crohn disease].
    Schreiber S; Gehrckens A; Raedler A
    Zentralbl Chir; 1995; 120(2):135-44. PubMed ID: 7709665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI appearance of perianal carcinoma in Crohn's disease.
    Lad SV; Haider MA; Brown CJ; Mcleod RS
    J Magn Reson Imaging; 2007 Dec; 26(6):1659-62. PubMed ID: 17968942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.